Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has The Infectious Disease Therapeutics Market Growth Evolved From 2024 To 2025, And What’s Ahead?
In the past few years, the infectious disease therapeutics market has experienced substantial expansion. Its size is projected to increase from $141.08 billion in 2024 to $150.6 billion in 2025, representing a compound annual growth rate (CAGR) of 6.7%. Factors contributing to this growth during the historic period include increased instances of infectious diseases, a rise in viral diseases, growing awareness about diagnostic measures, an increased need for swift and efficient diagnostic tests, and escalating demand for economical generic medications. Other factors, such as the burgeoning prevalence of infectious diseases and the rising significance of antimicrobial stewardship, also play key roles in this growth.
The market size of therapeutics for infectious diseases is projected to experience robust growth in the coming years, increasing to$191.97 billion in 2029″ with a compound annual growth rate (CAGR) of 6.3%. This anticipated growth throughout the forecast period can be credited to an influx of investments, the broadening scope of clinical trial studies, a rising number of these trials, a heightened emphasis on preventing infectious diseases, an increased alertness towards early diagnosis, and growing education and funding. Key trends for the forecast period encompass partnerships, product approvals, investments, and therapeutic research and developments.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15594&type=smp
What are the Fundamental Drivers and Innovations Shaping the Infectious Disease Therapeutics Market?
The surging occurrence of infectious diseases is forecasted to fuel the expansion of the infectious disease therapeutics market in the future. These diseases are the result of harmful microorganisms including bacteria, viruses, fungi, parasites, or prions. Several contributing factors like environmental disruption and climate change, antimicrobial resistance, weakened immune responses, increased interactions with animals and ecological disturbances have led to an increase in such infectious diseases. The imperative role that infectious disease therapeutics play includes treating these infections, reducing the incidence of sickness and death, and managing the dissemination of communicable diseases within communities and across entire populations. To illustrate, the Centers for Disease Control and Prevention, a government agency based in the US, reported that in 2022, there were 8,331 tuberculosis (TB) cases recorded in the United States with an incidence rate of 2.5 per 100,000 people. This signified a 5.9% surge in the case numbers and a 5.5% rise in the incidence rate compared to 2021. Thus, the increasing occurrence of infectious diseases propels the infectious disease therapeutics market.
How Is the Infectious Disease Therapeutics Market Segmented?
The infectious disease therapeuticsmarket covered in this report is segmented –
1) By Type: Drugs; Vaccines
2) By Disease: Tuberculosis; HIV/AIDS; Influenza; Hepatitis; Other Diseases
3) By End-User: Hospitals And Clinics; Retail Pharmacies; Research Organizations; Other End Users
Subsegments:
1) By Drugs – Antibiotics; Antivirals; Antifungals; Antiparasitics; Other Therapeutic Drugs (Monoclonal Antibodies, Immunomodulators)
2) By Vaccines – Inactivated Vaccines; Live Attenuated Vaccines; Subunit Vaccines; Mrna Vaccines; Dna Vaccines; Toxoid Vaccines
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=15594&type=smp
Which Regions Are Driving the Next Phase of the Infectious Disease Therapeutics Market Growth?
North America was the largest region in the infectious disease therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Key Trends Are Shaping the Future of the Infectious Disease Therapeutics Market?
Major firms active in the infectious disease therapeutics market are channeling funds into infectious disease drugs with the objectives of devising stronger treatments, curbing antimicrobial resistance, broadening their product ranges, and combatting emerging infectious threats. They aim through these investments to better meet patient needs, address gaps in medical treatment, and support global public health endeavors in controlling and managing infectious diseases. For instance, GSK, a healthcare company originating from the UK, dedicated £1 billion ($1.09 billion) in June 2022 towards addressing infectious diseases prevalent in less affluent countries. The goal of this project is to heighten research and development efforts against diseases that disproportionally impact these areas. The lack of balance in health research funding between affluent and low to middle-income countries highlights the crucial need for such preventive investments to promote health equality.
View the full report here:
How Is the Infectious Disease Therapeutics Market Defined and What Are Its Core Parameters?
Infectious disease therapeutics refers to the various treatments and interventions aimed at combating illnesses caused by pathogenic microorganisms such as bacteria, viruses, fungi, and parasites. The goal of infectious disease therapeutics is to either eliminate the infectious agent from the body or to control its replication and spread, thereby alleviating symptoms, preventing complications, and ultimately promoting recovery.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15594
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model